U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Tobacco Products
  3. Tobacco Science & Research
  4. Research
  5. Establishing Baseline Levels of Biomarkers of HPHCs in Tobacco Smoke and Smokeless Tobacco Products
  1. Research

Establishing Baseline Levels of Biomarkers of HPHCs in Tobacco Smoke and Smokeless Tobacco Products

Principal Investigator: Ben Blount / Maocheng (Tony) Yang

Funding Mechanism: Interagency Agreement

ID number: 224-10-9022

Award Date: 1/1/2011

Institution: Centers for Disease Control and Prevention

Establishing baseline levels of exposure to harmful and potentially harmful constituents (HPHCs) in tobacco products may help establish the relationship between HPHC levels and consumer risk. Using a variety of new analytical methods, the laboratory will analyze urine samples from adult, non-institutionalized, civilian, self-identified smokers in order to establish baseline biomarker levels. This baseline data may be used to inform manufacturer application review, development of product standards and other regulatory activities.

Back to Top